טוען...
Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis
BACKGROUND: Allergic bronchopulmonary aspergillosis (ABPA) is an allergic reaction to colonisation of the lungs with the fungus Aspergillus fumigatus and affects around 10% of people with cystic fibrosis. ABPA is associated with an accelerated decline in lung function. High doses of corticosteroids...
שמור ב:
| הוצא לאור ב: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley & Sons, Ltd
2016
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6734115/ https://ncbi.nlm.nih.gov/pubmed/27820955 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD002204.pub4 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|